The DOI matches its Crossref record; 386 of the 386 references it cites were found in a registry or an index.
Sex differences in cancer mechanisms
Open accessAbstract
We now know that cancer is many different diseases, with great variation even within a single histological subtype. With the current emphasis on developing personalized approaches to cancer treatment, it is astonishing that we have not yet systematically incorporated the biology of sex differences into our paradigms for laboratory and clinical cancer research. While some sex differences in cancer arise through the actions of circulating sex hormones, other sex differences are independent of estrogen, testosterone, or progesterone levels. Instead, these differences are the result of sexual differentiation, a process that involves genetic and epigenetic mechanisms, in addition to acute sex hormone actions. Sexual differentiation begins with fertilization and continues beyond menopause. It affects virtually every body system, resulting in marked sex differences in such areas as growth, lifespan, metabolism, and immunity, all of which can impact on cancer progression, treatment response, and survival. These organismal level differences have correlates at the cellular level, and thus, males and females can fundamentally differ in their protections and vulnerabilities to cancer, from cellular transformation through all stages of progression, spread, and response to treatment. Our goal in this review is to cover some of the robust sex differences that exist in core cancer pathways and to make the case for inclusion of sex as a biological variable in all laboratory and clinical cancer research. We finish with a discussion of lab- and clinic-based experimental design that should be used when testing whether sex matters and the appropriate statistical models to apply in data analysis for rigorous evaluations of potential sex effects. It is our goal to facilitate the evaluation of sex differences in cancer in order to improve outcomes for all patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
Research works printed but not linked: 19
- Rampen FH. Malignant melanoma: sex differences in response to chemotherapy? Eur J Cancer Clin Oncol. 1982;18:107–10. · doi:10.1016/0277-5379(82)90033-5
- Farahati, J., Bucsky, P., Parlowsky, T., Mader, U. & Reiners, C. Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology. Cancer 80, 2156-2162, doi:10.1002/(sici)1097-0142(19971201)80:11 < 2156::aid-cncr16 > 3.0.co;2-y (1997). · doi:10.1002/(sici)1097-0142(19971201)80:11
- Lautrup, M. D. et al. Male breast cancer: a nation-wide population-based comparison with female breast cancer. Acta Oncol 57, 613-621, doi:10.1080/0284186X.2017.1418088 (2018). · doi:10.1080/0284186x.2017.1418088
- Muscat, JE. & Wynder, EL. Tobacco, alcohol, asbestos, and occupational risk factors for laryngeal cancer. Cancer 69, 2244-2251, doi:10.1002/1097-0142(19920501)69:9 < 2244::aid-cncr2820690906 > 3.0.co;2-o (1992). · doi:10.1002/1097-0142(19920501)69:9
- Polednak, AP. & Flannery, JT. Brain, other central nervous system, and eye cancer. Cancer 75, 330-337, doi:10.1002/1097-0142(19950101)75:1 + <330::aid-cncr2820751315 > 3.0.co;2-5 (1995). · doi:10.1002/1097-0142(19950101)75:1
- Swango PA. Cancers of the oral cavity and pharynx in the United States: an epidemiologic overview. J Public Health Dent. 1996;56:309–18. · doi:10.1111/j.1752-7325.1996.tb02458.x
- Tota JE, et al. Rising incidence of oral tongue cancer among white men and women in the United States, 1973-2012. Oral Oncol. 2017;67:146–52. https://doi.org/10.1016/j.oraloncology.2017.02.019. · doi:10.1016/j.oraloncology.2017.02.019
- Franceschi E, et al. The prognostic roles of gender and O6-methylguanine-DNA methyltransferase methylation status in glioblastoma patients: the female power. World Neurosurg. 2018;112:e342–7. https://doi.org/10.1016/j.wneu.2018.01.045. · doi:10.1016/j.wneu.2018.01.045
- Zhu J, Kong F, Xing L, Jin Z, Li Z. Prognostic and clinicopathological value of long noncoding RNA XIST in cancer. Clin Chim Acta. 2018;479:43–7. https://doi.org/10.1016/j.cca.2018.01.005. · doi:10.1016/j.cca.2018.01.005
- Jin M, et al. Long noncoding RNA JPX correlates with poor prognosis and tumor progression in non-small cell lung cancer by interacting with miR-145-5p and CCND2. Carcinogenesis. 2019. https://doi.org/10.1093/carcin/bgz125. · doi:10.1093/carcin/bgz125
- Yang F, et al. Identifying potential metastasis-related long non-coding RNAs, microRNAs, and message RNAs in the esophageal squamous cell carcinoma. J Cell Biochem. 2019;120:13202–15. https://doi.org/10.1002/jcb.28594. · doi:10.1002/jcb.28594
- Menezo YJ, Chouteau J, Torello J, Girard A, Veiga A. Birth weight and sex ratio after transfer at the blastocyst stage in humans. Fertil Steril. 1999;72:221–4. https://doi.org/10.1016/s0015-0282(99)00256-3. · doi:10.1016/s0015-0282(99)00256-3
- Peippo J, Kurkilahti M, Bredbacka P. Developmental kinetics of in vitro produced bovine embryos: the effect of sex, glucose and exposure to time-lapse environment. Zygote. 2001;9:105–13. · doi:10.1017/s0967199401001113
- Williams TJ. A technique for sexing mouse embryos by a visual colorimetric assay of the X-linked enzyme, glucose 6-phosphate dehydrogenase. Theriogenology. 1986;25:733–9. · doi:10.1016/0093-691x(86)90131-7
- van den Akker, CH., te Braake, FW., Weisglas-Kuperus, N. & van Goudoever, JB. Observational outcome results following a randomized controlled trial of early amino acid administration in preterm infants. J Pediatr Gastroenterol Nutr 59, 714-719, doi:10.1097/MPG.0000000000000549 (2014). · doi:10.1097/mpg.0000000000000549
- Krzymowski T, Stefanczyk-Krzymowska S. Advances in understanding the physiological mechanism of maternal immune tolerance to the embryo. Reprod Biol. 2012;12:265–70. https://doi.org/10.1016/j.repbio.2012.10.004. · doi:10.1016/j.repbio.2012.10.004
- Krauthacker B. Levels of organochlorine pesticides and polychlorinated biphenyls (PCBs) in human milk and serum collected from lactating mothers in the northern Adriatic area of Yugoslavia. Bull Environ Contam Toxicol. 1991;46:797–802. https://doi.org/10.1007/bf01689721. · doi:10.1007/bf01689721
- Kim KH, Young BD, Bender JR. Endothelial estrogen receptor isoforms and cardiovascular disease. Mol Cell Endocrinol. 2014;389:65–70. https://doi.org/10.1016/j.mce.2014.02.001. · doi:10.1016/j.mce.2014.02.001
- Linderholm B, Tavelin B, Grankvist K, Henriksson R. Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer? Br J Cancer. 1999;81:727–32. https://doi.org/10.1038/sj.bjc.6690755. · doi:10.1038/sj.bjc.6690755
Cited by
Sex and gender: modifiers of health, disease, and medicine
Mauvais-Jarvis, F., Bairey Merz, N., Barnes, P. J., Brinton, R. D., Carrero, J.-J., DeMeo, D. L., De Vries, G. J., Epperson, C. N., Govindan, R., Klein, S. L., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31561-0 · Cited by 2,001
Self-citationSex disparities matter in cancer development and therapy
Haupt, S., Caramia, F., Klein, S. L., Rubin, J. B., & Haupt, Y. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00348-y · Cited by 331
Self-citation
Metadata
- Authors
- Rubin, J. B., Lagas, J. S., Broestl, L., Sponagel, J., Rockwell, N., Rhee, G., Rosen, S. F., Chen, S., Klein, R. S., Imoukhuede, P., & Luo, J.
- Venue
- Biology of Sex Differences
- Published
- 2020-04-15
- Volume
- 11
- Issue
- 1
- Pages
- 17-17
- ISSN
- 2042-6410 (ISSN-L)
- OpenAlex
- W3016662185
- Cited by
- 366
- References
- 386
- FWCI
- 33.21
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- National Cancer Institute (CA174737)
- Children's Discovery Institute (N/A)
- Prayers from Maria (N/A)
- St Louis Children's Hospital Foundation (N/A)
- Foundation for Barnes-Jewish Hospital (N/A)
- Barnard Research Funds (N/A)
- Joshua's Great Things (N/A)
- National Institutes of Health (U19 AI083019, R01 NS052632, R01 AI101400)
- National Society for Multiple Sclerosis (N/A)
- National Science Foundation (1653925)
- American Heart Association (16SDG26940002)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sex differences in cancer mechanisms. https://app.cochat.ai/papers/10.1186/s13293-020-00291-x
- The paper
- Rubin, J. B., Lagas, J. S., Broestl, L., Sponagel, J., Rockwell, N., Rhee, G., Rosen, S. F., Chen, S., Klein, R. S., Imoukhuede, P., & Luo, J. (2020). Sex differences in cancer mechanisms. Biology of Sex Differences. https://doi.org/10.1186/s13293-020-00291-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.